Skip to main content
Fuan Pharmaceutical (Group)co.,Ltd logo

Fuan Pharmaceutical (Group)co.,Ltd — Investor Relations & Filings

Ticker · 300194 ISIN · CNE1000011G4 Shenzhen Stock Exchange Manufacturing
Filings indexed 2,014 across all filing types
Latest filing 2018-05-17 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300194

About Fuan Pharmaceutical (Group)co.,Ltd

https://www.fapharm.com

Fuan Pharmaceutical (Group) Co., Ltd. is an integrated pharmaceutical enterprise specializing in the research, development, production, and distribution of a wide range of chemical drugs. The company operates across the entire value chain, encompassing pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and finished dosage forms. Its product portfolio primarily focuses on anti-infectives, particularly cephalosporins and penicillins, as well as treatments for cardiovascular diseases, oncology, and respiratory conditions. Fuan Pharmaceutical maintains large-scale manufacturing facilities and emphasizes technological innovation to support its diverse pipeline of generic and specialized medications. The group serves both domestic and international markets, providing essential healthcare solutions through its network of subsidiaries and specialized production bases.

Recent filings

Filing Released Lang Actions
第三届董事会第二十次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at a board meeting of the company 福安药业(集团)股份有限公司. It details the approval of a director nomination and the scheduling of a shareholders' meeting. The text includes voting results and procedural compliance statements. There are no financial statements, audit information, or detailed financial data present. The document is not a full report but an announcement of board decisions. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management.
2018-05-17 Chinese
关于股东减持公司股份的提示性公告
Director's Dealing Classification · 100% confidence The document is a notification about a shareholder's reduction in company shares, specifically detailing the number of shares sold, the method of sale, and compliance with relevant securities regulations. It references shareholder and director shareholding reduction rules and provides specific data on shareholding before and after the transaction. There is no financial performance data, no mention of earnings, no management discussion, no legal proceedings, or other report types. The document is a formal announcement of a director/major shareholder's dealing in shares. Therefore, it fits the category of Director's Dealing (DIRS). The document length is short and focused solely on this transaction, confirming it is not a full report or announcement of a report publication.
2018-05-17 Chinese
第三届监事会第十九次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of a supervisory board meeting resolution, specifically about the resignation of a supervisor and the nomination of a new candidate. It includes details about the meeting date, attendance, and voting results. There is no financial data, no mention of annual or interim reports, earnings, or other financial disclosures. The content focuses on board/management changes, specifically the supervisory board, which is part of senior management or governance structure. Therefore, the document fits best under Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication, so it is not RPA or RNS.
2018-05-17 Chinese
关于补选董事的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the election of a new board member (汪伟) to replace a resigning director (文敏). It includes details about the nomination, the board meeting approving the nomination, and the candidate's background and shareholding information. There is no financial data or report content, but rather a corporate governance update about board composition. This fits the category of Board/Management Information (MANG). The document length is short and focused on management changes, not a full report or announcement of a report publication.
2018-05-17 Chinese
关于召开2018年第一次临时股东大会的通知
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed notice about convening the 2018 first extraordinary general meeting (临时股东大会) of 福安药业 (Fuan Pharmaceutical Group Co., Ltd.). It includes information about the meeting date, agenda items (such as election of directors and supervisors), voting procedures, registration methods, and proxy forms. There is no financial data, earnings information, or report content. The document serves as an official announcement to shareholders about the meeting and how to participate and vote. This fits the definition of a Proxy Solicitation & Information Statement (PSI), which provides materials sent to shareholders to inform and request votes for meetings. The document length is 4163 characters, which is consistent with a detailed meeting notice rather than a full report or a brief announcement. Therefore, the correct classification is PSI.
2018-05-17 Chinese
关于监事辞职及补选监事的公告
Board/Management Information Classification · 100% confidence The document is a public announcement from 福安药业 (Fuan Pharmaceutical) regarding the resignation of a supervisory board member (监事) and the nomination of a new candidate to fill the vacancy. It includes details about the resignation, the legal compliance of shareholding restrictions, and the candidate's biography. There are no financial statements, earnings data, or detailed management discussion. The document is an announcement about changes in the company's supervisory board, which falls under Board/Management Information (MANG). The document length is short (1206 characters), and it is not a report or a notice of a report publication, but a direct announcement of management changes.
2018-05-17 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.